Raje, Noopur http://orcid.org/0000-0003-3066-1275
Anderson, Kenneth http://orcid.org/0000-0002-6418-0886
Einsele, Hermann http://orcid.org/0000-0002-7680-0819
Efebera, Yvonne
Gay, Francesca
Hammond, Sarah P.
Lesokhin, Alexander M.
Lonial, Sagar http://orcid.org/0000-0002-8322-9323
Ludwig, Heinz http://orcid.org/0000-0002-3302-8726
Moreau, Philippe http://orcid.org/0000-0003-1780-8746
Patel, Krina
Ramasamy, Karthik http://orcid.org/0000-0003-3385-3707
Mateos, Maria-Victoria http://orcid.org/0000-0003-2390-1218
Funding for this research was provided by:
Pfizer
Article History
Received: 22 December 2022
Revised: 25 May 2023
Accepted: 21 June 2023
First Online: 1 August 2023
Competing interests
: N.R.: Funding, grants or contracts: Pfizer; Consulting fees: BMS, Janssen, Takeda, Abbvie, Pfizer, Sanofi, GSK; Honoraria: Pfizer, Sanofi, BMS, Janssen; Data safety monitoring or Advisory board: BMS, Janssen, Pfizer, Abbvie, AstraZeneca, GSK. K.A.: Consulting fees: Pfizer, Amgen, AstraZeneca, Janssen, Precision Biosciences; Leadership or fiduciary role in other board, society, committee or advocacy group: C4 Therapeutics, Dynamic Cell Therapies, Window, Starton. H.E.: Consulting fees and Honoraria: BMS/Celgene, Janssen, Amgen, Takeda, Sanofi, GSK, Novartis. Y.E.: Honoraria: Janssen, Takeda, GSK, Oncopeptide, Sanofi, Pfizer; Advisory Committee: Oncopeptide, Sanofi, GSK, Janssen, Pfizer, Takeda; Research funding: BMS; Independent Adjudication Committee: Takeda, Orca. F.G.: Consulting fees: Pfizer, Amgen, Roche, Oncopeptides, BMS; Honoraria: Amgen, Sanofi, BMS, Abbvie, Takeda, Janssen; Data safety monitoring or Advisory board: Janssen, Amgen, BMS, Pfizer, Abbvie, Roche, Oncopeptides, Sanofi, Takeda. S.P.H.: Research support: F2G, GSK, Merck, Scynexis; Advisory board: F2G, Pfizer. A.L.: Honoraria: Pfizer; Consulting fees: Pfizer, Janssen, Research funding: Pfizer, BMS, Genentech, Janssen; Speaking fee: Janssen; Patents: US20150037346A1, Personal fees: Arcellx. S.L.: Grants or contracts: Takeda, Janssen, BMS, Novartis; Consulting fees and Honoraria: Amgen, Takeda, Janssen, BMS, GSK, Novartis, Abbvie, Genentech, Celgene, Pfizer; Other financial or non-financial interests: TG therapeutics. H.L.: Grants or contracts: Takeda, Amgen, Sanofi; Consulting fees: Celgene, Janssen-Cilag, Takeda, Amgen, BMS, Sanofi, GSK, Pfizer; Honoraria: Celgene, Janssen-Cilag, Takeda, Amgen, BMS, Sanofi, GSK, Pfizer, Abbvie; Data safety monitoring or Advisory board: Celgene, Takeda, Amgen, BMS, Sanofi. P.M.: Honoraria: Celgene, Janssen, Abbvie, Sanofi, Takeda, Amgen, Pfizer. K.P.: Funding: Pfizer; Grants or contracts: BMS, Nektar, Allogene, Cellectis, Poseida, Takeda, Arcellx, Abbvie; Consulting fees: BMS, Janssen, Pfizer, Merck, Arcellx, Caribou Biosciences; Honoraria: Pfizer, BMS, Janssen, Karyopharm; Data safety monitoring or Advisory board: BMS, Janssen, Pfizer, Abbvie, AstraZeneca, GSK. K.R.: Honoraria and member of the board of directors/advisory committees: Amgen, Janssen, Takeda, BMS/Celgene, GSK, Oncopeptides, Adaptive Biotech, Karyopharm, Pfizer, Sanofi, EUSA Pharma; Research funding: Amgen, Janssen, Takeda, BMS/Celgene, GSK; Travel and conference registration: Amgen, Janssen, Takeda, BMS/Celgene. M.V.M.: Consulting fees: Janssen, Takeda, Amgen, Seagen, GSK; Honoraria and Data safety monitoring or Advisory board: Janssen, Celgene, Takeda, Amgen, GSK, Abbvie, Pfizer, Regeneron, Roche, Sanofi, Oncopeptides.